Trospium Chloride NDC 62135-742

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-742Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0742Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-742-60	62135074260	60 TABLET, FILM COATED in 1 BOTTLE (62135-742-60)Marketed from Aug 17, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trospium Chloride
Generic name (nonproprietary): trospium chloride
Active ingredients: Trospium chloride — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204945
Marketing start: Aug 30, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 62135-742_45ae46c5-6f2e-2662-e063-6394a90aa535SPL ID 45ae46c5-6f2e-2662-e063-6394a90aa535SPL set ID 801f2143-6816-4f34-b65d-16bb2cf07975RxCUI 857560UNII 1E6682427EUPC 0362135742607
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135074260 followed by a unit qualifier and the quantity

Package 62135-0742-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025.

Indications (excerpt from the label)

Trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. Trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204945

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204945
Product	Strength	Form · route	Labeler	Product NDC
Trospium Chloride	Trospium chloride 20 mg/1	Tablet, Film coatedOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-530
Trospium Chloride	Trospium chloride 20 mg/1	Tablet, Film coatedOral	MAJOR PHARMACEUTICALS	0904-7619
Trospium Chloride	Trospium chloride 20 mg/1	Tablet, Film coatedOral	Aphena Pharma Solutions - Tennessee, LLC	71610-812
Trospium Chloride	Trospium chloride 20 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7059
Trospium Chloride	Trospium chloride 20 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4593